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Abstract
 .The effect of reactive oxygen species ROS , generated by in vitro stimulation of isolated PMN upon the main GAG
components of mineralised and non-mineralised connective tissues was investigated. PMN were isolated from whole blood
 .y. . .and the production of the ROS superoxide O and hydroxyl radicals OH was stimulated by the addition of phorbol2
 .myristyl acetate PMA and PMA r FeCl –EDTA chelate respectively and their production assessed over a 24 h period.3
 .The glycosaminoglycans GAG , hyaluronan, chondroitin 4-sulphate and dermatan sulphate, were exposed to the ROS
fluxes, incubated at 378C for 1 h and 24 h. GAG fragmentation was examined by gel exclusion chromatography and
modification to hexuronic acid and hexosamine residues determined. Stimulation of PMN with PMA resulted in a burst of
O.y production for 1 h, which was sustained at a reduced level for 24 h. Fragmentation of GAG was observed for all GAG2
examined. Modification to the GAG was evident, with hyaluronan being more susceptible to loss of GAG residues than
sulphated GAG. Modification of sugar residues increased with the incubation time and loss of the hexuronic acid residues
was greater than loss of hexosamine residues. Addition of FeCl –EDTA chelate, which led to the generation of .OH and3
was sustained over the 24 h period, demonstrated similar trends of GAG modification although increased degradation and
loss of hexosamine and hexuronic acid were observed. GAG chains are constituents of PGs and their modification is likely
to affect the function of these macromolecules and be of importance in considering the pathogenesis of inflammatory
diseases, including periodontal diseases. q 1997 Elsevier Science B.V.
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1. Introduction
Several lines of evidence implicate polymorphonu-
 .clear leukocytes PMN as the primary mediators of
the host response against proliferating pathogenic
microbes during inflammatory diseases, such as peri-
w xodontal disease 1 . PMN have been demonstrated to
produce a range of antimicrobial factors, which in-
 .clude reactive oxygen species ROS , such as super-
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 .y.oxide radicals O , which are produced as part of2
w x .ythe respiratory burst 2–4 . In vivo, O are capable2
of reacting further with other ROS, such as hydrogen
peroxide, in the presence of transition metal ions to
. .produce the highly reactive hydroxyl radical OH
w x5 . Studies have indicated that PMN isolated from
patients with early-onset periodontitis generate more
elevated levels of O.y than PMN from control groups2
w x .y6–8 . Elevated O production have also been re-2
w xported during chronic apical periodontitis 9 and
w xadult periodontitis 10 . Whilst the production of ROS
by PMN provides a host protective role, evidence
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also suggests that ROS production leads to the de-
struction of extracellular matrix components, and has
led to ROS being increasingly implicated in the
connective tissue damage incurred during inflamma-
w xtory diseases 11,12 .
 .Proteoglycans PG and their constituent gly-
 .cosaminoglycans GAG are important extracellular
matrix components within connective tissues. By
virtue of their polyanionic nature carried on the GAG
chains, they have been implicated in binding to cal-
cium and hydroxyapatite crystals, thereby providing a
w xrole in regulating mineralisation 13,14 and in bind-
ing growth factors, such as transforming growth fac-
tor b , thus regulating their action on cellular func-
w xtions 15 . Mineralised connective tissues, such as
bone, contain predominantly small chondroitin 4-
w xsulphate PG species, decorin and biglycan 16,17
whilst soft connective tissues, such as skin, gingiva
and periodontal ligament contain small dermatan sul-
phate PGs together with the larger chondroitin sul-
w xphate PG, versican 18 . All connective tissues also
contain in varying amounts the non-sulphated GAG,
hyaluronan, which has been identified to interact with
larger PG species and has been proposed roles in the
control of local calcium concentration and remod-
elling of mineralised tissues.
ROS have been demonstrated to be capable of the
in vitro degradation of the major ECM components,
including collagen, PG and GAG, such as hyaluronan
w xusing cell-free systems 11,19–23 . Recent studies
have shown that non-sulphated GAG, such as
hyaluronan and chondroitin appear to be the most
susceptible to degradation in the presence of a ROS
flux. Fragmentation of the GAG chains and modifica-
tion of the hexuronic acid and hexosamine residues
was also apparent, whilst degradation of the sul-
phated GAG, dermatan sulphate and chondroitin sul-
w xphate was less significant 23 . However, in relation
to O.y production by PMN, only the fragmentation2
of hyaluronan has thus far been studied, with the
secondary formation of .OH from O.y in these sys-2
tems found to further enhance the degradative effects
w xobserved 24,25 . The degradation of sulphated GAG
by PMN released ROS has not been studied, yet such
alterations to the GAG structure are likely to influ-
ence the functioning of these macromolecules within
connective tissues.
The aim of the present study was therefore to
extend previous observations relating to the degrada-
tion of GAG by ROS and to examine the effect of
O.y and .OH produced by stimulated PMN in vitro2
on sulphated and non-sulphated GAG commonly pre-
sent in mineralised and non-mineralised connective
tissues. Such a system could provide a model more
representative of in vivo inflammatory conditions,
such as periodontal diseases, and may also allow for
an assessment of the findings of previous studies
which have examined the chemical modification of
GAG by ROS using a cell-free system.
2. Materials and methods
2.1. Isolation of PMN
PMN were isolated from freshly drawn blood by
Ficoll-Hypaque density gradient centrifugation. Pe-
ripheral blood was collected from healthy human
 .volunteers age range 20–30 years into sterile vacu-
tainers containing lithium heparin Becton Dickinson,
.Meylan Cedex, France . A double-layered Ficoll-Hy-
paque solution was prepared in 10 ml sterile conical-
bottomed test-tubes, consisting of a dense Ficoll-Hy-
 .paque layer 2.5 ml containing 9.5% Ficoll 400
 .Pharmacia LKB, Uppsala, Sweden , 17% Hypaque
solution sodium diatrizoate, Sanofi Winthrop, Sur-
.rey, UK , on which was layered a light Ficoll-Hy-
 .paque solution 2.5 ml of 8.17% Ficoll 400, 10%
Hypaque solution. In the preparation of the Ficoll-
Hypaque solutions all Ficoll 400 solutions were auto-
claved prior to the addition of the 45% Hypaque
 .stock solution. Heparinized blood 2.5 ml was lay-
ered onto the upper Ficoll-Hypaque layer and tubes
were centrifuged at 100 g for 45 min at room temper-
ature, which resulted in the formation of four definite
layers. The upper two layers consisting of plasma cell
lymphocytes and monocytes respectively, and the
lower fourth layer containing erythrocytes were dis-
carded, whilst the third layer containing the PMN
was transferred to a clean conical-bottomed test-tubes.
 .Equal volumes of phosphate buffered saline PBS
were added to the collected PMN layers and cen-
trifuged at 700 g for 5 min at room temperature. The
supernatant was removed and the PMN pellet was
washed once more in PBS, after which the pellet was
washed in an equal volume of RPMI-1640 medium
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 .phenol red free, Sigma , supplemented with 2 mM
 .L-glutamine ICN Biomedicals . The PMN pellet was
resuspended in 1 ml of RPMI-1640 medium phenol
.red free , 2 mM L-glutamine and maintained at 48C
prior to identification.
2.2. Identification of the isolated PMN
The isolated PMN were identified by cytological
staining with 1% methyl violet solution in 95%
ethanol containing 1% ammonium oxalate for 1 min,
washed with double-distilled water and air dried.
Cells were examined by light microscopy under oil
immersion.
Cell viability of the PMN was determined by
staining of the nuclear material with ethidium bro-
mide r acridine orange solution 50 mg of ethidium
bromide and 15 mg of acridine orange in 1 ml of 95%
ethanol and added to 49 ml double-distilled water.
1 ml of this solution was added to 100 ml of PBS
.prior to use , for 10 min at room temperature. Cells
were examined by ultraviolet microscopy under water
immersion and cells with green nuclear material were
regarded as being viable, whilst cells with orange
nuclear material were regarded as being non-viable.
Total cell counts were determined for PMN sus-
pensions, stained with 0.2% methyl violet solution in
2% acetic acid, using a haemocytometer and an
inverted optical light microscope. The PMN cell sus-
pensions were adjusted to a concentration of 1=107
cellsrml by dilution with RPMI-1640 medium phe-
.nol red free , 2 mM L-glutamine.
2.3. Detection of ROS generation by PMA stimulated
PMN
PMN were stimulated to produce O.y by addition2
 .of phorbol myristyl acetate PMA which activates
protein kinase C, a key enzyme in the respiratory
w x  .burst process 26 . PMA Sigma was prepared by
dissolving to 1 mgrml in ethanol and diluting to
500ngrml in phosphate buffered saline. O.y produc-2
tion by PMA stimulated PMN was monitored by the
w xmethod of Samuni et al 27 over a 24 h incubation
 6 .period. PMN 5=10 cellsrml were maintained at
378C in 2.5 ml of RPMI-1640 medium phenol red
.free , supplemented with 500 ngrml PMA. At timed
intervals, 100 ml aliquots of the stimulated cell sus-
pension were removed and added to 2 ml of RPMI-
 .1640 medium phenol free , containing 100 mM cy-
tochrome c and 200 unitrml catalase bovine liver,
.Sigma . Following a few minutes lag period, reduc-
tion of cytochrome c was monitored by increasing
absorbance at 550 nm. Rates of O.y production were2
calculated at each time interval against a reference
 .containing 62.5 unitsrml superoxide dismutase SOD
 .bovine erythrocytes, Sigma and using a molar ex-
tinction coefficient for cytochrome c of
21,000 molesrLrcm.
.OH were generated via the Haber-Weiss reaction,
by the addition of ferric ions which catalyses the
secondary formation of .OH from O .y produced by2
w x .the PMA stimulated PMN 5 . OH radicals were
detected via the degradation of 2-deoxy-D-ribose to
the 3C carbonyl compound, malondialdehyde, which
w xcan be quantitated spectroscopically 28 . In a total
volume of 2.5 ml RPMI-1640 medium phenol red
.  6 .free , 2 mM L-glutamine, PMN 5=10 cellsrml
 .were mixed with 10 mM deoxyribose Sigma and
100 mM FeCl –EDTA. A control was also estab-3
lished containing 62.5 unitsrml SOD, 200 unitsrml
catalase. PMA was added to a final concentration of
500 ngrml to initiate O.y generation and subsequent2
.OH production and the reaction mixtures were incu-
bated at 378C for 24 h. 200 ml aliquots were removed
at regular intervals and centrifuged at 650 g for
10 min. The supernatant was added to an equal vol-
ume of 2.8% trichloroacetic acid, 1% thiobarbituric
 .acid Sigma , 0.15 M sodium hydroxide, heated to
1008C for 20 min and cooled prior to measuring
absorbance at 532 nm against a blank reaction mix-
ture containing no PMA.
2.4. Exposure of GAG following exposure to ROS
generated by PMN
The GAG examined in this study were chondroitin
4-sulphate sodium salt, whale cartilage, approximate
.molecular weight 46 KDa , dermatan sulphate
sodium salt, porcine skin, approximate molecular
. weight 9–10 KDa and hyaluronan sodium salt, hu-
man umbilical cord, approximate molecular weight
.3000–6000 KDa and were all purchased from Sigma.
To a final volume of 1 ml RPMI-1640 medium,
2 mM L-glutamine, containing PMN at a cell density
of 5=106 cellsrml, the individual GAG were mixed
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to give a final concentration of 0.5 mgrml. O.y2
production was stimulated in the presence of the
GAG by addition of 500 ngrml PMA to the above
reaction mixture whilst .OH production was gener-
ated by the further addition of 100 mM FeCl –EDTA3
chelate. Control reaction mixtures included the incu-
bation of the GAG in the RPMI-1640 medium only;
incubation of the GAG in the presence of PMN
 6 .5=10 cellsrml only; incubation of the GAG in
 6 .the presence of PMN 5=10 cellsrml , 500 ngrml
PMA, 100 mM FeCl –EDTA chelate 62.5 unitsrml3
SOD, 200 unitsrml catalase. All reaction mixtures
were incubated at 378C for 1 h or 24 h and stored at
y208C until required for analysis.
2.5. Determination of glycosaminoglycan
fragmentation
Fragmentation of the GAG exposed to the ROS
fluxes for 1 h or 24 h, was assessed by gel exclusion
chromatography. 500 ml samples of the GAG reac-
tion mixtures were applied to a prepacked Superdex
 .75 HR 10r30 column fractionation range 3–70 kDa ,
incorporated into a FPLC system Pharmacia
.Biotechnology and eluted with 2 M guanidinium
chloride, 0.5 M sodium acetate, pH 6.8 at room tem-
perature. 1 ml fractions were collected and assayed
for hexuronic acid content by the method of Bitter
w xand Muir 29 .
2.6. Determination of the chemical modification of
GAG by ROS
Samples of the reaction mixtures containing GAG
exposed to ROS together with their appropriate con-
trols were assessed for total hexuronic acid content
w x w x29 and total hexosamine content 30 to identify
chemical modifications to the GAG structure.
3. Results
3.1. Production of ROS by PMN
Cytological identification of the isolated PMN
demonstrated the cell suspensions to be G98% pure,
whilst the percentage viability of the PMN was in-
variably calculated to be G99% for freshly isolated
cells, which was reduced to 60–70%, following incu-
bation at 378C for 24 h.
The average rates of O.y production by the PMA2
stimulated PMN at each time interval is shown in
Fig. 1. Upon stimulation the rates of O.y formation2
were observed to increase initially to a maximum of
1.5–1.7 nmolesrmlrmin and then decline to approxi-
mately 4–16% of this maxima, with production of
the radical persisting up to 24 h. The rate of .OH
production by the PMA stimulated PMN in the pres-
ence of the FeCl –EDTA chelate, as detected by the3
Fig. 1. Rates of O.y produced by PMA stimulated PMN over a 24 h incubation period.2
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Fig. 2. The detection of .OH, generated by PMA stimulated PMN in the presence of FeCl –EDTA chelate, as determined via the3
degradation of deoxyribose. PMN, PMA, FeCl –EDTA; - - - PMN, PMA, FeCl –EDTA, SOD and Catalase.3 3
degradation of deoxyribose to malondialdehyde, is
shown in Fig. 2. Production of the .OH radical was
evident throughout the 24 h period monitored. Addi-
tion of the O.y scavengers superoxide dismutase and2
catalase resulted in a significant reduction of .OH
generation.
3.2. Fragmentation of GAG following exposure to
ROS
The elution profiles for each of the GAG, hyaluro-
nan, chondroitin 4-sulphate and dermatan sulphate
following exposure to ROS, together with control
reaction mixtures, are shown in Fig. 3, Fig. 4 and
Fig. 5 respectively. Each of the GAG examined were
found to undergo similar patterns of fragmentation in
the presence of the ROS flux. No significant in-
creases in GAG fragmentation were evident follow-
ing more prolonged incubation periods of 24 h, com-
pared to the fragmentation induced over a 1 h incuba-
tion period. Control experiments in which each of the
GAG which were not exposed to PMN, or therefore a
ROS flux, eluted from the gel filtration column pre-
 .dominantly around the void volume V . However,o
in the presence of PMN with no PMA stimulation,
the hexuronic acid concentration of the V peak waso
reduced, with increased quantities of detectable hex-
uronic acid fragments eluting towards the V of thet
elution profile, suggesting fragmentation of the GAG
to lower molecular weight products. Following addi-
tion of PMA to the reaction mixtures, which resulted
in the production of O.y via stimulation of the respi-2
ratory burst in the PMN, greater GAG fragmentation
was demonstrated, as detected by greater reduction of
the V peak and increased hexuronic acid materialo
eluting towards the V . The most extensive fragmen-t
tation of the individual GAG examined was evident
when the PMN were stimulated with PMA in the
presence of a FeCl –EDTA chelate, which enhance3
the generation of .OH from O.y via the Haber-Weiss2
reaction. This fragmentation was partially inhibited
by the inclusion of SOD and catalase, which scav-
enge the O.y and H O reactants of the Haber-Weiss2 2 2
reaction, and therefore implied that the PMN derived
O.y and .OH subsequently formed were responsible2
for the GAG fragmentation observed.
3.3. Chemical modification to GAG following
exposure to ROS
The percentage modification to the chemical struc-
ture of hexosamine and hexuronic acid, within each
of the GAG examined, following exposure to a ROS
flux for 1 and 24 h are shown in Tables 1 and 2. The
mean of the percentage modification of hexosamine
and hexuronic acid were calculated by comparison to
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the total concentration of the saccharide residue pre-
sent in the control reaction mixture containing the
GAG only. The results demonstrate that GAG un-
dergo modification of both hexuronic acid and hex-
osamine residues in the presence of O.y and .OH2
fluxes, with the effects exerted increasing following
Fig. 3. Uronic acid profiles obtained following gel filtration of the fragmented products of hyaluronan following exposure to ROS
generated by PMN.
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prolonged exposure. The non-sulphated GAG,
hyaluronan, was found to show the greatest modifica-
tion of both hexuronic acid and hexosamine residues,
particularly in the presence of PMA stimulated PMN
and a FeCl –EDTA chelate. The control reaction3
mixture containing SOD plus catalase partly pre-
vented residue modification by scavenging O.y and2
H O , although some residue modification was evi-2 2
Fig. 4. Uronic acid profiles obtained following gel filtration of the fragmented products of chondroitin 4-sulphate following exposure to
ROS generated by PMN.
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dent in the presence of these antioxidants, possibly
due to the transient production of O.y and H O2 2 2
prior to their removal by SOD and catalase. The
modification of hexuronic acid and hexosamine
residues in the sulphated GAG was found to be
similar for both chondroitin 4-sulphate and dermatan
sulphate, although residue modification was slightly
less than with hyaluronan. Again, greatest residue
modification was observed in the presence of the .OH
flux, which was partially inhibited in the presence of
Fig. 5. Uronic acid profiles obtained following gel filtration of the fragmented products of dermatan sulphate following exposure to ROS
generated by PMN.
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Table 1
The percentage modification of hexosamine residues of glycosaminoglycans following exposure to reactive oxygen species
GAG q PMN q PMN and PMA q PMN, PMA and FeCl –EDTA q SOD and catalase3
1 h
HA 1.62"0.39 5.96"0.38 8.24"0.34 2.59"0.31
C4S 1.03"0.39 2.44"0.24 6.32"0.33 1.60"0.29
DS 1.26"0.44 3.49"0.50 6.86"0.44 2.12"0.41
24 h
HA 3.61"0.28 11.29"0.31 18.74"0.34 5.20"0.29
C4S 2.11"0.80 7.76"0.66 12.55"0.77 4.06"0.71
DS 2.67"0.37 7.35"0.49 12.96"0.47 4.82"0.43
Table 2
The percentage modification of hexuronic acid residues of glycosaminoglycans following exposure to reactive oxygen species
GAG q PMN q PMN and PMA q PMN, PMA and FeCl –EDTA q SOD and catalase3
1 h
HA 2.09"0.08 7.44"0.14 11.27"0.11 3.64"0.14
C4S 1.31"0.37 4.56"0.36 7.11"0.37 2.27"0.41
DS 1.79"0.23 5.16"0.32 8.38"0.38 2.72"0.17
24 h
HA 4.78"0.08 14.55"0.25 22.88"0.21 8.96"0.26
C4S 3.98"0.19 10.26"0.27 16.88"0.31 6.31"0.28
DS 4.17"0.64 9.86"0.60 17.12"0.55 7.09"0.57
the scavengers SOD and catalase. Of note, for each
of the GAG studied in this investigation, modification
of the hexuronic acid residues was marginally greater
than that observed for the hexosamine residues, sug-
gesting that the hexuronic acid residues of these
GAG are more susceptible to modification by ROS
than hexosamine residues.
4. Discussion
This study has established the ability of ROS,
particularly the O.y and .OH species, produced by2
PMN to degrade a variety of GAG present in non-
mineralised and mineralised connective tissues. The
degradative effect of these cellular derived ROS rein-
forces earlier chemical studies utilising cell-free sys-
tems for the generation of ROS and serves as a model
to investigate their nature during an inflammatory
condition such as periodontal disease. Periodontal
disease is unpredictable in its pathology, with periods
of active tissue destruction, periods of relative quies-
w xcence and periods of tissue healing 31–33 . The
short and prolonged periods of exposure, employed in
the present study, were in an attempt to relate the in
vitro generation of O.y by stimulated PMN and the2
enhanced production of .OH, to an in vivo situation
relating to the extracellular release of ROS by PMN
during initial bursts of activity and the more cumula-
tive periods of disease activity.
All the GAG examined were fragmented in the
presence of a ROS flux to greater or lesser extent,
although the nature of the ROS generated influenced
the degree of break down. As an example, GAG
fragmentation was particularly prominent when ex-
posed to .OH flux generated by PMA stimulated
PMN in the presence of the FeCl –EDTA chelate.3
Such findings support the proposal that .OH is highly
reactive in nature and may be the major radical
species responsible for the degradation of connective
tissue components during an inflammatory condition
w x19,23 . GAG degradation was not as extensive fol-
lowing exposure to O.y , generated by PMA stimu-2
lated PMN in the absence of the FeCl –EDTA3
chelate, compared to GAG exposed to .OH. It is
conceivable that the presence of contaminating transi-
tion metal ions in these reaction mixtures may also
promote the generation of small amounts of .OH.
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Small amounts of degradation of the GAG were also
observed in the presence of unstimulated PMN which
may be due to low transient levels of O .y produced2
spontaneously by the PMN and the generation of
.OH, again through transition metal ion contamina-
tion.
The present study has also identified chemical
modifications of both hexuronic acid and hexosamine
residues within the GAG molecules exposed to both
O.y and .OH. The non-sulphated GAG, hyaluronan2
was more susceptible to residue modification by ROS
than sulphated GAG, particularly following pro-
longed periods of exposure. In addition, the hex-
uronic acid residues within the GAG examined ap-
peared to be more susceptible to ROS modification
than the hexosamine residues. The results support
previous findings which suggest that non-sulphated
GAG are more prone to modification than sulphated
GAG and implies a protective function of the sul-
w xphate groups 23 . Detailed studies have recently
elucidated the precise mechanisms for the degrada-
tive effects of ROS on hyaluronan, which is thought
to occur via the random modification to the unit
monosaccharides, followed by the hydrolytic cleav-
age of the resulting unstable hydrolytic constituents,
with a range of hydrolytic products chemically char-
w xacterized 34 . In addition, it has been suggested that
O .y and .OH have different modes of action on2
w xsynovial hyaluronan 35 . Similar mechanisms for the
degradation of heparin by ROS have also been pro-
w xposed 36 .
The stimulation of PMN by PMA proved to be an
efficient source of O.y in vitro, with high level of2
.OH formation promoted in the presence of a FeCl –3
EDTA chelate. Maximum O.y production was ob-2
served within the first hour following stimulation of
the PMN, with a reduced but sustained level of
formation observed thereafter and compare with simi-
w x .lar findings reported by Samuni et al. 27 . OH
production was sustained at a constant level over 24 h
period. It would appear that the GAG are not exposed
to a constant ROS flux over the 24 h period of
investigation and the results indicate that there is
little further breakdown of the GAG chains following
24 h incubation periods compared with 1 h incubation
periods. However, significant differences relating to
the percentage chemical modification of the hex-
osamine and hexuronic acid residues at the two time
intervals studied were observed, suggesting that the
low level of ROS production observed over the 24 h,
following the initial burst within the first hour, is
capable of causing substantial chemical modification
to the GAG chains.
The fragmentation and chemical modification of
sulphated and non sulphated GAG have previously
been described following their exposure to ROS fluxes
w xgenerated by cell-free systems 11,23,34–36 . Al-
though the levels of ROS produced by stimulated
PMN are significantly less than that produced by the
oxidation of hypoxanthine by xanthine oxidase, the
level of fragmentation and modification of the GAG
chains observed following exposure to stimulated
PMN are very comparable to those previously re-
w xported using the cell-free system 23 and therefore
both provide good in vitro model systems to examine
matrix degradation in inflamed connective tissue.
When the two studies are considered together, the
results indicate the reactive nature of O.y and .OH,2
even at the relatively low levels likely to exist in vivo
during an inflammatory response, an observation sup-
ported by the apparent, although reduced, modifica-
tion to the GAG chains exposed to a ROS flux in the
presence of SOD and catalase.
The potential role of hydrolytic enzymes, derived
from PMN, in the GAG degradation observed is also
a contributing factor. However, PMN have been
demonstrated to contain no hyaluronidase activity
w x24 and as such indicates a role for ROS in the
degradative process detailed in this study. Further-
more, the lysosomal carbohydrases, b-D-glucuroni-
dase and b-N-acetylglucosaminidase, identified in the
 .primary azurophillic granules of PMN exert no
degradative effects upon intact GAG, although these
enzymes may have a role in the enzymic degradation
of GAG, following initial GAG degradation by ROS
w x21 .
The results presented in this study therefore pro-
vide valuable information regarding the mechanisms
of destruction of both mineralised and non-minera-
lised tissues during inflammatory diseases, such as
periodontal disease. Extensive degradation of gingi-
val PGs exposed to ROS produced by cell-free sys-
w xtems in vitro have been reported 11 and the prod-
ucts relate in size to PGs isolated from inflamed
w xgingival samples 37 . ROS have also been shown to
w xbe produced by osteoclasts 38 and may play a role
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in remodelling of bone in health and disease. In
considering the functional importance of the GAG
chains as constituents of PGs within the extracellular
matrix, the partial fragmentation and the chemical
modifications demonstrated in this study may not
only be of importance in considering connective tis-
sue destruction, but also have severe consequences
upon extracellular matrix synthesis, organisation and
repair.
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